Many Investors Still Treating Gilead: 4 Launches This Year Could Prove Them Wrong
Gilead sits at a crossroads: the HIV backbone remains strong, but a quartet of new launches could reshape the company...
Compare 401(k) options by evaluating index funds against target date funds to see which aligns with your retirement plan and risk tolerance.
25,660 articlesGilead sits at a crossroads: the HIV backbone remains strong, but a quartet of new launches could reshape the company...
Steak ’n Shake reports a 16% July lift in U.S. same-store sales and attributes it to Bitcoin adoption, but the absenc...
New York Governor Hochul’s decision to pause autonomous for-hire vehicle expansion outside NYC hits Waymo and Tesla’s...
Bitcoin rebounded back toward $65,000 after a volatile weekend tied to regional tensions. ETF flows returning to cent...
Anthropic has filed a federal lawsuit after being labeled a supply-chain risk by the government, arguing the move thr...
Playnance confirms G Coin launch ahead of its March 18 Token Generation Event, underscoring a live ecosystem with hun...
A March 17, 2026 report from Muddy Waters Research targets SoFi Technologies, spurring volatility as KBW weighs in. S...
Anchorage Digital is introducing institutional custody for TRX, a regulatory milestone that could reshape near-term p...
Adobe stock faces a challenging year but shows signs of a turnaround as AI monetization accelerates and enterprise de...
Boston travelers gain access to offsite security under the TSA’s straight gate pilot as Delta and JetBlue begin testi...
When regulators and exchanges join forces to reverse a settlement, it signals a new chapter in crypto enforcement. Th...
Rambus navigates a cooling memory-chip cycle that could weigh on margins even as AI infrastructure demand remains a k...